Screener
Novanta NOVT Medical Solutions — Restructuring Costs
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Novanta in its filing.
Tagged under the XBRL concept us-gaap:RestructuringCosts.
The source filing: Novanta’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 5:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-335404
FAQ
- What is Novanta's medical solutions — restructuring costs?
- Novanta (NOVT) reported medical solutions — restructuring costs of $961K in Q2 2026.
- How has Novanta's medical solutions — restructuring costs changed year-over-year?
- Novanta's medical solutions — restructuring costs decreased by 77.1% year-over-year, from $4.2M to $961K.
- What is the long-term trend for Novanta's medical solutions — restructuring costs?
- Over 4 years (2021 to 2025), Novanta's medical solutions — restructuring costs has grown at a 73.7% compound annual growth rate (CAGR), from $813K to $7.41M.
- What does medical solutions — restructuring costs mean?
- Expenses incurred to reorganize, consolidate, or streamline operations within the Medical Solutions segment to improve long-term efficiency. These costs typically include severance, facility closures, and other exit activities associated with strategic business realignment.
Ask your AI about Novanta's medical solutions — restructuring costs.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude